University Health Network, Toronto: COVID-19 trials

The registry lists 20 COVID-19 studies with University Health Network, Toronto as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 1 2Phase 2 1Phase 3 2Phase 4 1No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Swallowing Impairment After COVID-19 InfectionCompletedNCT04537650Results posted
• Pilot Open Label Use of the Hi-OXSR for the Treatment of Post COVID-19 Cognitive DysfunctionCompletedNCT06379620Phase 1
• SafeTy and Efficacy of Preventative CoVID VaccinesStatus unknownNCT05208983
• The Canadian COVID-19 Prospective Cohort StudyActive, not recruitingNCT05125510
• Cardiovascular Disease and Outcomes Among Patients With SARS-CoV-2 Infection (COVID-19)Status unknownNCT05085262
• Immune Response to COVID-19 Vaccine in Immunotherapy (IO) and Non-IO Treated Cancer PatientsCompletedNCT05062525
• TOGETHER - Toronto: Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19Status unknownNCT04967430Phase 3
• Third Dose of Moderna COVID-19 Vaccine in Transplant RecipientsCompletedNCT04885907Phase 4
• Enhanced Triage for COVID-19CompletedNCT04750369
• Covid-19 Airway ManagementCompletedNCT04689724
• A Research Platform to Screen Healthcare Workers- Coordinated Approach to Pandemic Trials of COVID-19CompletedNCT04574765
• Study of Decidual Stromal Cells to Treat COVID-19 Respiratory FailureCompletedNCT04451291Not applicable
• Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and SeverityCompletedNCT04439045Phase 3
• Virtual Assistant for COVID-19 PPEStatus unknownNCT04435275Not applicable
• Mental Health Outcomes in Healthcare Workers During COVID-19CompletedNCT04397848
• High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients)CompletedNCT04383002Phase 1
• Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care WorkersStatus unknownNCT04373096Not applicable
• Screening of Cancer Patients to Assess Impact of COVID-19TerminatedNCT04373005
• Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19CompletedNCT04354259Phase 2
• Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 PneumoniaTerminatedNCT04331665Not applicable